Evidence map›Paper›PMID 33102201›Full record

ArticleFrontiers in oncology2020

Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up.

Anthony Ricco, Gabrielle Barbera, Rachelle Lanciano, Jing Feng, Alexandra Hanlon, Alicia Lozano, Michael Good, Stephen Arrigo, John Lamond, Jun Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Anthony RiccoVirginia Commonwealth University Health System, Richmond, VA, United States.
Gabrielle BarberaCollege of Medicine, Drexel University, Philadelphia, PA, United States.
Rachelle LancianoRadiation Oncology, Crozer-Keystone Health System, Springfield, PA, United States.
Jing FengPhiladelphia CyberKnife Center, Havertown, PA, United States.
Alexandra HanlonVirginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Alicia LozanoVirginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Michael GoodPhiladelphia CyberKnife Center, Havertown, PA, United States.
Stephen ArrigoRadiation Oncology, Crozer-Keystone Health System, Springfield, PA, United States.
John LamondRadiation Oncology, Crozer-Keystone Health System, Springfield, PA, United States.
Jun YangPhiladelphia CyberKnife Center, Havertown, PA, United States.
Crozer-Keystone Health System · USVirginia Tech · USDrexel University · USUniversity Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

high risk prostate cancerintermediate risk prostate cancerprostate cancerprostate SBRT treatmentSBRT (stereotactic body radiation therapy)

Identifiers

PMID33102201
PMCPMC7545336
OpenAlexW3088323103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.